Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

From 50+ Known Issues to Zero:

How CSA Transformed Our Validation Approach A Veeva QMS Implementation Success Story

In an era where pharmaceutical companies are challenged to maintain compliance while accelerating their digital transformation, we partnered for a  groundbreaking validation transformation for a commercial-stage biopharmaceutical company. This case study demonstrates how embracing Computer Software Assurance (CSA) principles revolutionized our Veeva QMS implementation across QualityDocs, Change Control, and Training modules.

EvoLV is dedicated to providing tailored consulting services that address unique challenges and unlock new opportunities for growth in the life sciences industry.

Innovative solution in medicine

Services Delivered:

  • CSV/CSA Strategy Development
  • Team Training & Transformation
  • Risk-Based Testing Implementation
  • Quality Documentation  Enhancement
  • Vendor Partnership Management
Plants are fundamental to humans and fascinating to study

1. CSV/CSA Strategy Development

The foundation of our success lay in completely reimagining the validation approach. We integrated CSA principles with GAMP 5 2nd Edition guidance to create a robust yet efficient validation strategy. Our team developed a comprehensive risk-based framework that prioritized critical functionality while streamlining validation efforts for lower-risk elements.

Key Achievements:

  • Revised SOPs to align with FDA's CSA draft guidance
  • Implemented risk-based assessment methodologies
  • Created clear decision trees for validation approaches
  • Established justified rationales for testing strategies
Innovation Concept

2. Team Training & Transformation 

Success required more than just new procedures – it demanded a mindset shift. We implemented a comprehensive training program that transformed how teams approached validation.

Key Components:

  • Interactive CSA workshops for all stakeholders
  • Risk assessment training sessions
  • Cross-functional collaboration frameworks
  • Real-time feedback and adaptation mechanisms
The future of medicine is here

3. Risk-Based Testing Implementation

We revolutionized the testing approach by implementing a sophisticated risk-based testing strategy that optimized resource allocation while enhancing quality assurance.

Innovations:

  • Developed clear risk categorization criteria
  • Implemented unscripted testing for low-risk requirements
  • Enhanced test coverage for high-risk functionalities
  • Reduced documentation overhead by 50% for low-risk items
Medical innovation

4. Quality Documentation Enhancement 

Our approach transformed documentation from a burden into a strategic asset, ensuring compliance while improving efficiency.

Improvements:

  • Streamlined documentation processes
  • Electronic execution implementation
  • Enhanced traceability matrix
  • Automated cross-referencing
Working on futuristic genetic research!

5. Vendor Partnership Management

Leveraging 5+ years of Veeva expertise, we established a strategic partnership that accelerated issue resolution and knowledge transfer.

Partnership Benefits:

  • Direct access to Veeva expertise
  • Rapid issue resolution pathways
  • Knowledge sharing workshops
  • Proactive risk mitigation
Working Together

Results

The transformation from traditional CSV to CSA yielded remarkable improvements:

Quantitative Results:

  • Reduced known issues at launch from 50+ to minimal
  • 50% reduction in scripting time for low-risk requirements
  • 100% team adoption of new CSA principles
  • Zero critical issues in Phase 2 launch


Qualitative Improvements:

  • Enhanced team collaboration and morale
  • Improved vendor relationships
  • More robust system validation
  • Better resource utilization
  • Increased stakeholder confidence

Ready to transform your validation approach?

Let's discuss how we can help you implement CSA principles in your organization.